OBJECTIVE: To investigate high-risk breast cancer survivors' risk reduction decision making and decisional conflict after an uninformative BRCA1/2 test. DESIGN: Prospective, longitudinal study of 182 probands undergoing BRCA1/2 testing, with assessments 1-, 6-, and 12-months postdisclosure. MEASURES: Primary predictors were health beliefs and emotional responses to testing assessed 1-month postdisclosure. Main outcomes included women's perception of whether they had made a final risk management decision (decision status) and decisional conflict related to this issue. RESULTS: There were four patterns of decision making, depending on how long it took women to make a final decision and the stability of their decision status across assessments. Late decision makers and nondecision makers reported the highest decisional conflict; however, substantial numbers of women--even early and intermediate decision makers--reported elevated decisional conflict. Analyses predicting decisional conflict 1- and 12-months postdisclosure found that, after accounting for control variables and decision status, health beliefs and emotional factors predicted decisional conflict at different timepoints, with health beliefs more important 1 month after test disclosure and emotional factors more important 1 year later. CONCLUSION: Many of these women may benefit from decision making assistance. Copyright 2009 APA, all rights reserved.
OBJECTIVE: To investigate high-risk breast cancer survivors' risk reduction decision making and decisional conflict after an uninformative BRCA1/2 test. DESIGN: Prospective, longitudinal study of 182 probands undergoing BRCA1/2 testing, with assessments 1-, 6-, and 12-months postdisclosure. MEASURES: Primary predictors were health beliefs and emotional responses to testing assessed 1-month postdisclosure. Main outcomes included women's perception of whether they had made a final risk management decision (decision status) and decisional conflict related to this issue. RESULTS: There were four patterns of decision making, depending on how long it took women to make a final decision and the stability of their decision status across assessments. Late decision makers and nondecision makers reported the highest decisional conflict; however, substantial numbers of women--even early and intermediate decision makers--reported elevated decisional conflict. Analyses predicting decisional conflict 1- and 12-months postdisclosure found that, after accounting for control variables and decision status, health beliefs and emotional factors predicted decisional conflict at different timepoints, with health beliefs more important 1 month after test disclosure and emotional factors more important 1 year later. CONCLUSION: Many of these women may benefit from decision making assistance. Copyright 2009 APA, all rights reserved.
Authors: F C Murphy; J S Rubinsztein; A Michael; R D Rogers; T W Robbins; E S Paykel; B J Sahakian Journal: Psychol Med Date: 2001-05 Impact factor: 7.723
Authors: David Cella; Chanita Hughes; Amy Peterman; Chih-Hung Chang; Beth N Peshkin; Marc D Schwartz; Lari Wenzel; Amy Lemke; Alfred C Marcus; Caryn Lerman Journal: Health Psychol Date: 2002-11 Impact factor: 4.267
Authors: Thomas S Frank; Amie M Deffenbaugh; Julia E Reid; Mark Hulick; Brian E Ward; Beth Lingenfelter; Kathi L Gumpper; Thomas Scholl; Sean V Tavtigian; Dmitry R Pruss; Gregory C Critchfield Journal: J Clin Oncol Date: 2002-03-15 Impact factor: 44.544
Authors: Kathryn L Taylor; Rebecca A Shelby; Marc D Schwartz; Josh Ackerman; V Holland LaSalle; Edward P Gelmann; Colleen McGuire Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-07 Impact factor: 4.254
Authors: Jamie C Brehaut; Annette M O'Connor; Timothy J Wood; Thomas F Hack; Laura Siminoff; Elisa Gordon; Deb Feldman-Stewart Journal: Med Decis Making Date: 2003 Jul-Aug Impact factor: 2.583
Authors: Michael A Andrykowski; Jessica L Burris; Erin Walsh; Brent J Small; Paul B Jacobsen Journal: J Clin Oncol Date: 2010-05-24 Impact factor: 44.544
Authors: Suzanne C O'Neill; Heiddis B Valdimarsdottir; Tiffani A Demarco; Beth N Peshkin; Kristi D Graves; Karen Brown; Karen E Hurley; Claudine Isaacs; Sharon Hecker; Marc D Schwartz Journal: Breast Cancer Res Treat Date: 2010-04-10 Impact factor: 4.872
Authors: Allecia E Reid; Rebecca A Ferrer; Sanjana Kadirvel; Barbara B Biesecker; Katie L Lewis; Leslie G Biesecker; William M P Klein Journal: Soc Sci Med Date: 2020-06-23 Impact factor: 4.634
Authors: Suzanne C O'Neill; Darren Mays; Andrea Farkas Patenaude; Judy E Garber; Tiffani A DeMarco; Beth N Peshkin; Katherine A Schneider; Kenneth P Tercyak Journal: J Community Genet Date: 2014-08-07
Authors: Sharon Manne; Deborah Kashy; Terrance Albrecht; Yu-Ning Wong; Anne Lederman Flamm; Al B Benson; Suzanne M Miller; Linda Fleisher; Joanne Buzaglo; Nancy Roach; Michael Katz; Eric Ross; Michael Collins; David Poole; Stephanie Raivitch; Dawn M Miller; Tyler G Kinzy; Tasnuva Liu; Neal J Meropol Journal: Med Decis Making Date: 2013-11-18 Impact factor: 2.583